Is suffering a sufficient legitimation for UTx?
Bioethics · 2023
DOI: 10.1111/bioe.13135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioethics, 2023. Verfasst von Claudia Bozzaro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Medicine, Christian-Albrechts-Universitat zu Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Infertility, Female, Organ Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Uterus transplantation is a relatively new intervention. A woman with absolute uterine factor infertility receives, by a surgical procedure, a transplanted uterus, most often by living donation. The uterus recipient may thus become pregnant and conceive her own child. As with any other medical treatment, UTx requires legitimation. The anticipated benefits must outweigh the risks of the medical intervention. The risks and benefits of UTx are by no means unequivocal and cannot be easily determined. The benefits depend on the final evaluation of the suffering to be alleviated by the intervention. In the following, we will analyze the suffering addressed by UTx and discuss its normative value. First, we point out that (a) suffering is generally considered an important normative criterion in medicine as well as in the context of UTx; (b) we then describe the risks and anticipated benefits of UTx for the three persons directly concerned: the child, the donor, and the recipient; (c) we further analyze the suffering addressed by UTx. The intervention addresses a form of existential suffering. We discuss the common notion that existential suffering should be evaluated from the subjective perspective of the sufferer; (d) afterwards, we argue that in a social practice like medicine, a one‐sided evaluation stemming from the sufferer alone is not sufficient; and (e) finally, arguments from a societal perspective lead us to the conclusion that the existential suffering addressed by UTx does not possess a sufficiently strong normative value to legitimize a high‐risk, expensive procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Experimental Medicine, Christian-Albrechts-Universitat zu Kiel, Kiel, Germany.
- Institute for Medical Ethics and History of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany.
ORCID-Profile: Claudia Bozzaro
Zitieren
APA
Bozzaro, C., Weismann, M., Westermann, A. M., & Alkatout, I. (2023). Is suffering a sufficient legitimation for UTx?. Bioethics. https://doi.org/10.1111/bioe.13135
Vancouver
Bozzaro C, Weismann M, Westermann AM, Alkatout I. Is suffering a sufficient legitimation for UTx?. Bioethics. 2023. doi:10.1111/bioe.13135
BibTeX
@article{Bozzaro2023,
author = {Bozzaro, Claudia and Weismann, Melanie and Westermann, Anna Maria and Alkatout, Ibrahim},
title = {Is suffering a sufficient legitimation for UTx?},
journal = {Bioethics},
year = {2023},
doi = {10.1111/bioe.13135}
}
EUVIMED